Fuji Pharma Co (FRA:FUP) ROCE %: 3.68% (As of Mar. 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
84 GF Score
Price €11.60
GF Value €9.61
! 5 Warning Signs
View Full Analysis

What is Fuji Pharma Co ROCE %?

Fuji Pharma Co FRA:FUP -6.45% 84 ROCE % is 3.68% as of Mar. 2026. GuruFocus rates FRA:FUP with a GF Score™ of 84/100 and a GF Value™ of €9.61. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fuji Pharma Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.68%.

Fuji Pharma Co  (FRA:FUP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fuji Pharma Co ROCE % Related Terms

Fuji Pharma Co ROCE % Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co ROCE % Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.05 7.62 7.98 15.39 7.12

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.01 6.61 8.81 1.74 3.68
FRA:FUP
84GF Score
Fuji Pharma Co Ltd FRA:FUP
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co ROCE % Calculation

Fuji Pharma Co's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=24.95/( ( (567.245 - 225.619) + (538.208 - 178.556) )/ 2 )
=24.95/( (341.626+359.652)/ 2 )
=24.95/350.639
=7.12 %

Fuji Pharma Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=12.908/( ( (520.786 - 177.05) + (533.873 - 176.039) )/ 2 )
=12.908/( ( 343.736 + 357.834 )/ 2 )
=12.908/350.785
=3.68 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.68% mean?
Fuji Pharma Co (FRA:FUP) has a ROCE % of 3.68% as of Mar. 2026.
Is Fuji Pharma Co's ROCE % too high?
Fuji Pharma Co's current ROCE % is 3.68%. The Drug Manufacturers industry median ROCE % is 7.00. Fuji Pharma Co's value of 3.68% is 47.4% below this industry median. Overall, Fuji Pharma Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's ROCE % compare to ZTS?
Fuji Pharma Co's ROCE % of 3.68% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Fuji Pharma Co's value of 3.68% is 47.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fuji Pharma Co's current ROCE % of 3.68% is 47.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuji Pharma Co's current ROCE % is 3.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current ROCE % of 3.68%. The stock's GF Value™ is €9.61, compared to a current price of €11.60 — trading 20.7% above its estimated fair value. The current ROCE % is 3.68% and 47.4% below the Drug Manufacturers industry median of 7.00. Fuji Pharma Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current ROCE % is 3.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €11.60 is trading 20.7% above its estimated GF Value™ of €9.61.

Key valuation signals for FRA:FUP:

  • ROCE %: 3.68%
  • GF Value™: €9.61 vs. price of €11.60 (20.7% above fair value)
  • GF Score™: 84/100 with 5 warning signs
  • Industry Position: 47.4% below the Drug Manufacturers median

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
84GF Score

Get the complete analysis for FRA:FUP

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.60
Price
€9.61
GF Value